Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Oct 28;16(1):207.
doi: 10.1186/s12872-016-0379-z.

Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies

Tian Zuo  1   2 , Xuehui Liu  3 , Lu Jiang  1 , Shuai Mao  1   2 , Xin Yin  1   2 , Liheng Guo  4   5
Affiliations
Review

Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies

Tian Zuo et al. BMC Cardiovasc Disord. .

Abstract

Background: Hyperuricemia may be associated with an increased risk of coronary heart disease (CHD) mortality; however, the results from prospective studies are conflicting. The objective of this study was to assess the association between hyperuricemia and risk of CHD mortality by performing a meta-analysis.

Methods: Pubmed and Embase were searched for relevant prospective cohort studies published until July 2015. Studies were included only if they reported data on CHD mortality related to hyperuricemia in a general population. The pooled adjusted relative risk (RR) was calculated using a random-effects model.

Results: A total of 14 studies involving 341 389 adults were identified. Hyperuricemia was associated with an increased risk of CHD mortality (RR: 1.14; 95 % CI: 1.06-1.23) and all-cause mortality (RR: 1.20; 95 % CI: 1.13-1.28). For each increase of 1 mg/dl of serum uric acid (SUA), the overall risks of CHD and all-cause mortality increased by 20 and 9 %, respectively. According to the gender subgroup analyses, hyperuricemia increased the risk of CHD mortality in women (RR: 1.47; 95 % CI: 1.21-1.73) compared to men (RR: 1.10; 95 % CI: 1.00-1.19). The risk of all-cause mortality was greater in women.

Conclusions: Hyperuricemia may modestly increase the risk of CHD and all-cause mortality. Future research is needed to determine whether urate-lowering therapy has beneficial effects for reducing CHD mortality.

Keywords: Coronary heart disease; Hyperuricemia; Meta-analysis; Mortality.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Search strategy
Fig. 2
Fig. 2
Forest plot of association between hyperuricemia and coronary heart disease mortality
Fig. 3
Fig. 3
Forest plot of association between an increase of 1 mg/dl in serum uric acid level and coronary heart disease mortality
Fig. 4
Fig. 4
Forest plot of association between hyperuricemia and all-cause mortality
Fig. 5
Fig. 5
Forest plot of association between an increase of 1 mg/dl in serum uric acid level and all-cause mortality
See this image and copyright information in PMC

References

    1. Gertler MM, Garn SM, Levine SA. Serum uric acid in relation to age and physique in health and in coronary heart disease. Ann Intern Med. 1951;34(6):1421–1431. doi: 10.7326/0003-4819-34-6-1421. - DOI - PubMed
    1. Klein R, Klein BE, Cornoni JC, Maready J, Cassel JC, Tyroler HA. Serum uric acid. Its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia. Arch Intern Med. 1973;132(3):401–410. doi: 10.1001/archinte.1973.03650090077014. - DOI - PubMed
    1. Brand FN, McGee DL, Kannel WB, Stokes J, 3rd, Castelli WP. Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol. 1985;121(1):11–18. - PubMed
    1. Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol. 1995;141(7):637–644. - PubMed
    1. Wannamethee SG, Shaper AG, Whincup PH. Serum urate and the risk of major coronary heart disease events. Heart. 1997;78(2):147–153. doi: 10.1136/hrt.78.2.147. - DOI - PMC - PubMed